Cytogam
Biological
CSL Behring
Total Payments
$2.1M
Transactions
31
Doctors
11
Companies
3
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $4,800 | 1 | 1 |
| 2021 | $907.00 | 2 | 2 |
| 2020 | $35,270 | 13 | 10 |
| 2019 | $1.7M | 5 | 1 |
| 2018 | $321,298 | 10 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $1.7M | 2 | 82.5% |
| Unspecified | $321,250 | 9 | 15.4% |
| Consulting Fee | $40,507 | 13 | 1.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,070 | 4 | 0.1% |
| Travel and Lodging | $673.55 | 1 | 0.0% |
| Education | $47.52 | 1 | 0.0% |
| Food and Beverage | $22.08 | 1 | 0.0% |
Payments by Type
General
$1.8M
22 transactions
Research
$321,250
9 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Randomized Trial to Prevent Congenital Cytomegalovirus CMV | CSL Behring | $321,250 | 0 |
Top Doctors Receiving Payments for Cytogam
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Salt Lake City, UT | $2.0M | 11 |
| , MD | Pediatrics | Richmond, VA | $17,296 | 4 |
| , MD | Pediatrics | Minneapolis, MN | $6,000 | 2 |
| , MD | Infectious Disease | Boston, MA | $4,000 | 3 |
| John Fung | Transplant Surgery | Chicago, IL | $3,407 | 2 |
| Vinay Sundaram | — | Los Angeles, CA | $3,305 | 2 |
| Josh Levitsky | — | Chicago, IL | $3,000 | 1 |
| , M.D | Surgery | Los Angeles, CA | $3,000 | 1 |
| , M.D | Obstetrics & Gynecology | Winston Salem, NC | $1,500 | 1 |
| , M.D., PHD | Transplant Surgery | Houston, TX | $1,328 | 2 |
| , M.D | Internal Medicine | Cincinnati, OH | $437.00 | 1 |
| , MD | Internal Medicine | Miami, FL | $47.52 | 1 |
Ad
Manufacturing Companies
- CSL Behring $2.0M
- Saol Therapeutics Inc. $27,273
- Saol International Limited $16,000
Product Information
- Type Biological
- Total Payments $2.1M
- Total Doctors 11
- Transactions 31
About Cytogam
Cytogam is a biological associated with $2.1M in payments to 11 healthcare providers, recorded across 31 transactions in the CMS Open Payments database. The primary manufacturer is CSL Behring.
Payment data is available from 2018 to 2022. In 2022, $4,800 was paid across 1 transactions to 1 doctors.
The most common payment nature for Cytogam is "Royalty or License" ($1.7M, 82.5% of total).
Cytogam is associated with 1 research study, including "A Randomized Trial to Prevent Congenital Cytomegalovirus CMV" ($321,250).